Your position：Home > Industry Information

Internationalization of plant extracts industry faces challenges, should enhance international competitiveness

Chinese plant extractive industry is currently the most likely sub-industry in the field of Chinese medicine, but due to the inconsistency of standards and lack of corresponding market supervision departments, it is difficult to form industry self-discipline and industrial concentration, resulting in many companies still remain in the chemical industry , And the overall size of the company is relatively small, the international competitiveness is not strong, in the future to become a powerful plant extraction industry has a long way.

The status of international plant extract market

In recent years, the steady increase in the demand for plant extracts in developed countries and regions in the world, especially in Europe and the United States, has greatly stimulated the development of the industry. Global sales of plant extracts reached US$10.14 billion in 2006, reaching US$33.32 billion in 2016, with an average annual growth rate of 12.63%.

International competitiveness of plant extracts in China needs to be improved

From 2010 to 2015, China's overall export volume of the plant extract industry has grown from less than US$1 billion to more than US$2.5 billion. The annual increase in the export scale of plant extracts in China can not be separated from the technical breakthroughs and model innovations that the private enterprises in China have continuously achieved over the years; nor can the policies and incentives of the national policies on the export of the industry are indispensable; at the same time, the accreditation process of the industry standards has been accelerated. It also objectively promotes China's continuous integration with international plant extracts and even its leading position. Driven by many parties, the international competitiveness of China's plant extract industry is constantly improving.

However, after the international financial crisis, the three major markets in Europe, the United States, and Japan have shown a strong localization trend. They have imposed new requirements on the prices, costs, and safety of extractive products. Chinese companies are facing international markets. challenge.

The first is the localization trend that each market presents. The European market promotes unsaturated fatty acid products, mainly originating in Norway and other Nordic countries; the Japanese market has become the mainstream product of fermentation and bean products, while China has few such products; the top seven products that are popular in the US market are localized products. Weakening the trend of Chinese products.

Second, global extract product innovation is slow, prices and costs have become the focus of competition, and the days when Chinese companies originally relied on large companies in Europe and the United States to launch star products every year to drive the market are gone forever.

Third, Chinese extract products are becoming a synonym for “big goods” and “cheap goods”. Once they are “namely”, market competitiveness will be difficult to guarantee, and the development of the market will be worrisome.

In this situation, China's plant extracts enterprises must improve their competitiveness as quickly as possible, and plan and upgrade their products, standards, quality control, innovation capabilities, and corporate development strategies in order to promote the healthy development of China's extractive industries.



Sichuan Benepure Pharmaceutical Co., Ltd. is committed to human health.

Welcome to contact with us.

Hotline: +86 028-8679 9990;+86 028-86799914;+86 028-8679 8880.

Email: sales@benepure.com



Previous：The industry prospects of plant extracts are very promising
Next：Research indicates that vitamin D3 supplementation can help repair damage to the cardiovascular system